Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADAP Adaptimmune Therapeutics plc

交易中 12-05 14:36:01 EST

0.0549

+0.0000

0.00%

最高0.0549	最低0.0549	成交量0.00
今开0.0549	昨收0.0549	日振幅0.00%
总市值1,455万	流通市值1,005万	总股本2.65亿
成交额0.00	换手率0.00%	流通股本1.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADAP","market":"US","secType":"STK","nameCN":"Adaptimmune Therapeutics plc","latestPrice":0.0549,"timestamp":1764963361226,"preClose":0.0549,"halted":0,"volume":0,"delay":0,"floatShares":183084412,"shares":265051591,"eps":-0.657397,"marketStatus":"交易中","change":0,"latestTime":"12-05 14:36:01 EST","open":0.0549,"high":0.0549,"low":0.0549,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.657397,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1764968400000},"marketStatusCode":2,"adr":1,"adrRate":6,"listingDate":1430884800000,"exchange":"NASDAQ","adjPreClose":0.0549,"volumeRatio":0},"requestUrl":"/m/hq/s/ADAP","defaultTab":"news","newsList":[{"id":"2572582555","title":"Adaptimmune Therapeutics Plc盘中异动 临近午盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572582555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572582555?lang=zh_cn&edition=full","pubTime":"2025-09-30 23:34","pubTimestamp":1759246479,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日23时34分，Adaptimmune Therapeutics Plc股票出现波动，股价快速下挫5.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Scisparc Ltd.、Zura Bio Limited、Anaptysbio, Inc.涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2033.05%、313.01%、274.74%，振幅较大的相关个股有Zura Bio Limited、Klotho Neurosciences Inc C/Wts 21/06/2029 、Anaptysbio, Inc.，振幅分别为50.84%、35.39%、32.23%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930233439971a901f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930233439971a901f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2556838297","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大跌9.89%报0.072美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556838297","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556838297?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314353,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下挫9.89%。截至发稿，该股报0.072美元/股，成交量536.071万股，换手率2.02%，振幅2.88%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.60%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213233a6d2833e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213233a6d2833e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","ADAP","BK4139","BK4539"],"gpt_icon":0},{"id":"2546732731","title":"瑞穗银行：下调Adaptimmune Therapeutics(ADAP.US)评级，由优于大市调整至中性评级, 目标价由1.50美元调整至0.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546732731","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546732731?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:03","pubTimestamp":1750950212,"startTime":"0","endTime":"0","summary":"瑞穗银行：下调Adaptimmune Therapeutics(ADAP.US)评级，由优于大市调整至中性评级, 目标价由1.50美元调整至0.50美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/26230351331897.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ADAP","LENZ","161121"],"gpt_icon":0},{"id":"2543608194","title":"Adaptimmune Therapeutics Plc盘中异动 急速拉升5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608194","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608194?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:33","pubTimestamp":1750080806,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时33分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅上涨5.53%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Sage Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Processa Pharmaceuticals, Inc.、Pmgc Holdings Inc.较为活跃，换手率分别为1130.27%、183.75%、35.81%，振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Klotho Neurosciences Inc C/Wts 21/06/2029 、Vaxart, Inc. - Common Stock，振幅分别为30.36%、30.00%、10.97%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213326a70c346b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213326a70c346b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2537113782","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537113782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537113782?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:00","pubTimestamp":1748008811,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时00分，Adaptimmune Therapeutics Plc股票出现波动，股价急速跳水5.21%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Imunon, Inc.、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Polyrizon Ltd.、Imunon, Inc.、Nucana Plc较为活跃，换手率分别为2023.21%、1467.81%、526.06%，振幅较大的相关个股有Abpro Holdings Inc C/Wts 12/11/2029 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Imunon, Inc.，振幅分别为208.33%、106.67%、62.58%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052322001197635826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052322001197635826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2536674639","title":"Adaptimmune Therapeutics Plc盘中异动 大幅拉升6.12%报0.295美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536674639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536674639?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:36","pubTimestamp":1747672592,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日00时36分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅拉升6.12%。截至发稿，该股报0.295美元/股，成交量31.3267万股，换手率0.12%，振幅4.68%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.20%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520003632aa2c9306&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520003632aa2c9306&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2536592648","title":"Adaptimmune Therapeutics Plc2025财年第一财季实现净利润-47.77百万美元，同比增加1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536592648","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536592648?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584096,"startTime":"0","endTime":"0","summary":"5月19日，Adaptimmune Therapeutics Plc公布财报，公告显示公司2025财年第一财季净利润为-47.77百万美元，同比增加1.46%；其中营业收入为7.31百万美元，同比增加28.92%，每股基本收益为-0.19美元。从资产负债表来看，Adaptimmune Therapeutics Plc总负债1.96亿美元，其中短期债务4.63百万美元，资产负债比为0.81，流动比率为0.03。机构评级：截至2025年5月19日，当前有7家机构对Adaptimmune Therapeutics Plc目标价做出预测，其中目标均价为1.59美元，其中最低目标价为0.46美元，最高目标价为3.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000552a6e3a86f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000552a6e3a86f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2535071166","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨7.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535071166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535071166?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:03","pubTimestamp":1747234992,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时03分，Adaptimmune Therapeutics Plc股票出现波动，股价急速上涨7.80%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.41%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。该信息摘要如下：富国银行：维持Adaptimmune Therapeutics评级，由持股观望调整至持股观望评级, 目标价由1.50美元调整至1.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423031294f6da98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423031294f6da98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ","BK4007","BK4539"],"gpt_icon":0},{"id":"2535079571","title":"巴克莱：维持Adaptimmune Therapeutics(ADAP.US)评级，由减持调整至减持评级, 目标价由1.00美元调整至0.46美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535079571","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535079571?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:54","pubTimestamp":1747234450,"startTime":"0","endTime":"0","summary":"巴克莱：维持Adaptimmune Therapeutics(ADAP.US)评级，由减持调整至减持评级, 目标价由1.00美元调整至0.46美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14225450394652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2535690079","title":"富国银行：维持Adaptimmune Therapeutics(ADAP.US)评级，由持股观望调整至持股观望评级, 目标价由1.50美元调整至1.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535690079","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535690079?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:45","pubTimestamp":1747233956,"startTime":"0","endTime":"0","summary":"富国银行：维持Adaptimmune Therapeutics(ADAP.US)评级，由持股观望调整至持股观望评级, 目标价由1.50美元调整至1.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14224550394597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2535722822","title":"Adaptimmune Therapeutics(ADAP.US)：2025年Q1财报实现营收728.5万美元，前值为567.8万美元，预期值为655万美元；每股收益为-0.03美元，前值为-0.03美元，预期值为-0.17美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535722822","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535722822?lang=zh_cn&edition=full","pubTime":"2025-05-13 19:41","pubTimestamp":1747136462,"startTime":"0","endTime":"0","summary":"Adaptimmune Therapeutics(ADAP.US)：2025年Q1财报实现营收728.5万美元，前值为567.8万美元，预期值为655万美元；每股收益为-0.03美元，前值为-0.03美元，预期值为-0.17美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/13194150355621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2534208311","title":"Adaptimmune Therapeutics Plc盘中异动 快速上涨5.71%报0.309美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534208311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534208311?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:46","pubTimestamp":1747057575,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时46分，Adaptimmune Therapeutics Plc股票出现波动，股价急速拉升5.71%。截至发稿，该股报0.309美元/股，成交量7.0559万股，换手率0.03%，振幅2.22%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为2.96%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221461694f484af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221461694f484af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","ADAP","BK4139","BK4007"],"gpt_icon":0},{"id":"2532008905","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532008905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532008905?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:31","pubTimestamp":1746106273,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时31分，Adaptimmune Therapeutics Plc股票出现波动，股价快速下跌5.10%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Transcode Therapeutics, Inc.、Kalaris Therapeutics, Inc.涨幅较大，Processa Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Onconetix, Inc.较为活跃，换手率分别为27.15%、14.68%、10.13%，振幅较大的相关个股有Kalaris Therapeutics, Inc.、Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.，振幅分别为9.41%、9.19%、9.10%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213113aa2c8049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501213113aa2c8049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2531688799","title":"Adaptimmune Therapeutics Plc盘中异动 急速下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531688799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531688799?lang=zh_cn&edition=full","pubTime":"2025-04-30 03:51","pubTimestamp":1745956293,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日03时51分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下跌5.41%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Biocardia, Inc.、Kala Bio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Ibio, Inc.较为活跃，换手率分别为173.22%、172.82%、147.96%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Ibio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为134.52%、54.29%、50.68%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430035134974a8ca0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430035134974a8ca0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2530935281","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅拉升5.96%报0.281美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530935281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530935281?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:31","pubTimestamp":1745847086,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.96%。截至发稿，该股报0.281美元/股，成交量1.7166万股，换手率0.01%，振幅0.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.35%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家商业化阶段的生物制药公司，致力于通过细胞疗法重新定义实体瘤的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821312797488d92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821312797488d92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2518027975","title":"Adaptimmune Therapeutics Plc盘中异动 快速下挫5.12%报0.455美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518027975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518027975?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:11","pubTimestamp":1741619463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时11分，Adaptimmune Therapeutics Plc股票出现波动，股价急速跳水5.12%。截至发稿，该股报0.455美元/股，成交量33.2454万股，换手率0.13%，振幅6.19%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3561.12%、944.59%、796.47%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231103abf320f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231103abf320f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2517620071","title":"Adaptimmune Therapeutics Plc盘中异动 快速跳水5.01%报0.481美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517620071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517620071?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276867,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时01分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.01%。截至发稿，该股报0.481美元/股，成交量19.1667万股，换手率0.07%，振幅6.93%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.47%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000108989ec595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000108989ec595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2516630868","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630868?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:21","pubTimestamp":1741015310,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时21分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下跌5.11%。截至发稿，该股报0.512美元/股，成交量21.6999万股，换手率0.08%，振幅8.52%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1780.98%、134.75%、117.36%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303232150abe64392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303232150abe64392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2516330316","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516330316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516330316?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:14","pubTimestamp":1740770093,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时14分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.10%。截至发稿，该股报0.523美元/股，成交量57.6599万股，换手率0.23%，振幅8.17%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.16%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031454abe129ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031454abe129ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2514336413","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.16%报0.557美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514336413?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:26","pubTimestamp":1740677217,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时26分，Adaptimmune Therapeutics Plc股票出现异动，股价急速跳水5.16%。截至发稿，该股报0.557美元/股，成交量58.8597万股，换手率0.23%，振幅7.56%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Ibio, Inc.、Pepgen Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1722.67%、296.54%、125.38%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为86.14%、50.65%、47.79%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228012657abdf9765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228012657abdf9765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptimmune.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.339},{"period":"6month","weight":-0.806},{"period":"1year","weight":-0.9216},{"period":"ytd","weight":-0.8981}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptimmune Therapeutics Plc成立于2014年12月3日，是一家根据英格兰和威尔士法律注册成立的公众有限公司。该公司是一家临床阶段的生物制药公司，将于2024年过渡到商业阶段的细胞治疗公司。该公司专注于为癌症患者提供新型细胞疗法。公司第一个产品，afamitresgene autoleucel或“afami-cel”是滑膜肉瘤特有的，将是肉瘤产品专营的第一个产品。他们计划于2026年在美国商业推出的Lete-cel将是肉瘤专营权的第二个产品，将同时针对滑膜肉瘤和粘液样圆细胞脂肪肉瘤，显著扩大可治疗的患者群体。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.24176},{"month":2,"riseRate":0.3,"avgChangeRate":0.006803},{"month":3,"riseRate":0.4,"avgChangeRate":-0.056152},{"month":4,"riseRate":0.7,"avgChangeRate":0.101482},{"month":5,"riseRate":0.4,"avgChangeRate":0.154958},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.053678},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.072088},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.043688},{"month":9,"riseRate":0.454545,"avgChangeRate":0.076796},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.249842},{"month":11,"riseRate":0.363636,"avgChangeRate":0.050929},{"month":12,"riseRate":0.4,"avgChangeRate":0.005688}],"exchange":"NASDAQ","name":"Adaptimmune Therapeutics plc","nameEN":"Adaptimmune Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptimmune Therapeutics plc,ADAP,Adaptimmune Therapeutics plc股票,Adaptimmune Therapeutics plc股票老虎,Adaptimmune Therapeutics plc股票老虎国际,Adaptimmune Therapeutics plc行情,Adaptimmune Therapeutics plc股票行情,Adaptimmune Therapeutics plc股价,Adaptimmune Therapeutics plc股市,Adaptimmune Therapeutics plc股票价格,Adaptimmune Therapeutics plc股票交易,Adaptimmune Therapeutics plc股票购买,Adaptimmune Therapeutics plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}